Literature DB >> 30448596

Pathology Characterization and Detection of Human Papillomavirus Type 16 in Rectal Squamous Cell Carcinomas.

Anna E Coghill1, Andrew M Bellizzi2, Charles F Lynch3, Meredith S Shiels4, Freda R Selk5, Maura Gillison6, Brenda Y Hernandez7, Owen T M Chan7, Eric A Engels4.   

Abstract

Rectal squamous cell carcinoma (SCC) is a rare tumor with unresolved etiology. Human immunodeficiency virus-infected individuals and solid organ transplant recipients experience >30-fold and approximately 3-fold elevated rates of rectal SCC, respectively, suggesting immunosuppression plays a role.1 Human immunodeficiency virus-infected homosexual men have >60-fold higher rates of rectal SCC, similar to anal SCC. These patterns, which differ from the more common rectal adenocarcinoma (AdCA), raise the possibility of shared etiology between rectal and anal SCC, with human papillomavirus type 16 (HPV16) being a likely candidate.2.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30448596      PMCID: PMC6520215          DOI: 10.1016/j.cgh.2018.11.006

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  8 in total

1.  Rectal squamous cell carcinoma in immunosuppressed populations: is this a distinct entity from anal cancer?

Authors:  Anna E Coghill; Meredith S Shiels; Randi K Rycroft; Glenn Copeland; Jack L Finch; Anne M Hakenewerth; Karen S Pawlish; Eric A Engels
Journal:  AIDS       Date:  2016-01-02       Impact factor: 4.177

2.  Human papillomavirus type 16-associated primary squamous cell carcinoma of the rectum.

Authors:  K Sotlar; G Köveker; C Aepinus; H C Selinka; R Kandolf; B Bültmann
Journal:  Gastroenterology       Date:  2001-03       Impact factor: 22.682

3.  Sexually transmitted infection as a cause of anal cancer.

Authors:  M Frisch; B Glimelius; A J van den Brule; J Wohlfahrt; C J Meijer; J M Walboomers; S Goldman; C Svensson; H O Adami; M Melbye
Journal:  N Engl J Med       Date:  1997-11-06       Impact factor: 91.245

4.  Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method.

Authors:  C C Huang; J T Qiu; M L Kashima; R J Kurman; T C Wu
Journal:  Mod Pathol       Date:  1998-10       Impact factor: 7.842

5.  Squamous-cell carcinoma of the rectum: a rare but curable tumor.

Authors:  Caio S R Nahas; Jinru Shia; Romane Joseph; Deborah Schrag; Bruce D Minsky; Martin R Weiser; Jose G Guillem; Phillip B Paty; David S Klimstra; Laura H Tang; W Douglas Wong; Larissa K Temple
Journal:  Dis Colon Rectum       Date:  2007-09       Impact factor: 4.585

6.  Low etiologic fraction for human papillomavirus in larynx squamous cell carcinoma.

Authors:  M Taberna; C Resteghini; B Swanson; R K L Pickard; B Jiang; W Xiao; M Mena; P Kreinbrink; E Chio; M L Gillison
Journal:  Oral Oncol       Date:  2016-08-31       Impact factor: 5.337

Review 7.  Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis.

Authors:  Andrew E Grulich; Marina T van Leeuwen; Michael O Falster; Claire M Vajdic
Journal:  Lancet       Date:  2007-07-07       Impact factor: 79.321

8.  Role of human papillomavirus in squamous cell metaplasia-dysplasia-carcinoma of the rectum.

Authors:  Christina S Kong; Mark L Welton; Teri A Longacre
Journal:  Am J Surg Pathol       Date:  2007-06       Impact factor: 6.394

  8 in total
  2 in total

1.  Comparing Human Papillomavirus Prevalence in Rectal and Anal Cancer Using US Cancer Registries, 2014-2015.

Authors:  Jacqueline Mix; Mona Saraiya; Charles F Lynch; Trevor D Thompson; April Greek; Thomas C Tucker; Edward S Peters; Troy D Querec; Elizabeth R Unger
Journal:  J Registry Manag       Date:  2019

2.  Cancer risk following lymphoid malignancies among HIV-infected people.

Authors:  Parag Mahale; Chinenye Ugoji; Eric A Engels; Meredith S Shiels; Sally Peprah; Lindsay M Morton
Journal:  AIDS       Date:  2020-07-01       Impact factor: 4.632

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.